Skip to search formSkip to main contentSkip to account menu

Neurontin

a kind of pain relieving drug
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
For the past 40 years, there has been no major addition to the repertoire of drugs for treating severe, chronic pain. Now, two… 
Review
2003
Review
2003
Background Gabapentin was first approved by the FDA in 1993 as an add‐on treatment for partial epileptic seizures. In May of 2002… 
Highly Cited
2002
Highly Cited
2002
The actions of the anticonvulsant gabapentin [1-(aminomethyl)cyclohexaneacetic acid, Neurontin] have been somewhat enigmatic… 
Review
2002
Review
2002
OBJECTIVE The use of gabapentin, an antiepileptic agent, in a primary care setting was evaluated to determine (a) the conditions… 
Highly Cited
2002
Highly Cited
2002
Gabapentin (GBP; Neurontin®) and pregabalin (PGB; CI‐1008), efficacious drugs in several neurological and psychiatric disorders… 
Highly Cited
2001
Highly Cited
2001
Highly Cited
2001
PURPOSE Refractory genitourinary pain is a common but difficult condition to treat. Examples of chronic genitourinary pain… 
Highly Cited
2000
Highly Cited
2000
A 48-year-old male suffering with SUNCT (severe unilateral neuralgiform headache with conjunctival injection and tearing… 
Highly Cited
1995
Highly Cited
1995
Gabapentin, an analog of gamma-aminobutyric acid, exhibits anticonvulsant properties in both animal models and humans. Gabapentin…